Crescent Capital BDC, Inc. filings document the regulatory record of a business development company that invests in secured debt, unsecured debt and related equity securities of private U.S. middle-market companies. Its Form 8-K reports include operating and financial results, dividend announcements, material agreements, capital-structure disclosures and other material events.
Proxy materials describe annual meeting voting matters, board governance and director elections. The filing record also identifies the company’s registered securities, including common stock listed under CCAP and exchange-listed notes, and provides formal disclosure around governance changes, shareholder matters, risk topics and financing arrangements.
Crescent Capital BDC, Inc. (CCAP) reported that major stockholder Fidelity & Guaranty Life Insurance Company, a ten percent owner, filed a Form 4 for open-market sales of CCAP common stock executed under a Rule 10b5-1 trading plan. On September 8, 2026, an affiliated entity sold 126,436 shares at a volume weighted average price of $10.3322 in multiple trades within a $10.285–$10.45 range. On September 9, 2026, it sold a further 139,054 shares at a volume weighted average price of $10.2288 across trades in a $10.18–$10.28 range. The shares are held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person.
Crescent Capital BDC, Inc. (CCAP) reported that Fidelity & Guaranty Life Insurance Company, a ten percent owner, filed to disclose open-market sales of a total of 15,482 shares of common stock on September 3–4, 2026, executed under a Rule 10b5-1 trading plan. The shares are held through Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary, and were sold in multiple transactions at volume-weighted average prices.
Crescent Capital BDC, Inc. (CCAP) has a notice of proposed sale under Rule 144 filed on behalf of Fidelity & Guaranty Life Insurance, identified as a 10% stockholder. The filing covers a proposed sale of 525,000 shares of common stock through Keefe, Bruyette & Woods on NASDAQ on or after August 24, 2026, with an aggregate market value of $5,118,750.
The notice states that Crescent Capital BDC, Inc. has 36,845,952 shares outstanding, and that the selling stockholder originally acquired 4,205,307 shares of common stock in the issuer’s November 16, 2021 initial public offering for cash.
Crescent Capital BDC, Inc. (CCAP) reported that Fidelity & Guaranty Life Insurance Company, a ten percent owner, sold a total of 56,285 shares of Common Stock in open-market or private transactions on September 1 and September 2, 2026, under a Rule 10b5-1 trading plan.
The reported sales consisted of 11,285 shares at $10.50 per share on September 1 and 45,000 shares at a volume-weighted average price of about $10.44 per share on September 2, with execution prices ranging from $10.38 to $10.59. Some of the reported holdings are owned by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person.
Crescent Capital BDC, Inc. (CCAP) reported that ten percent owner Fidelity & Guaranty Life Insurance Company sold shares of its common stock in late August 2026. The reporting person sold 15,000 shares on August 28, 2026 at a volume-weighted average price of $10.6020 and 40,000 shares on August 31, 2026 at a volume-weighted average price of $10.6205, both as open-market transactions under a Rule 10b5-1 trading plan. Footnotes state that the shares were sold in multiple trades within disclosed price ranges and that some shares are held through a wholly owned New York insurance subsidiary.
Crescent Capital BDC, Inc. (CCAP) reported that Fidelity & Guaranty Life Insurance Company, a ten percent owner, sold a total of 59,286 shares of common stock in two open-market transactions on August 26 and 27, 2026, at volume-weighted average prices around $10.60 per share. The filing notes these trades were made under a Rule 10b5-1 trading plan, and some shares are held through Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person.
Crescent Capital BDC, Inc. (CCAP) had a Form 4 filed by Fidelity & Guaranty Life Insurance Co, a ten percent owner, reporting net open-market sales of 73,457 shares of common stock. The sales on 2026-08-24 and 2026-08-25, executed under a Rule 10b5-1 trading plan, were made at volume-weighted average prices around $10.72–$10.80 per share. A portion of the reported shares is held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the reporting person.
Crescent Capital BDC, Inc. (CCAP) officer and director Henry Chung reported a purchase of 2,500 shares of Common Stock on August 19, 2026 at $10.89 per share in an open-market or private transaction. Following this transaction, he directly held 23,917 shares, which includes 695 shares acquired through dividend reinvestment in 2026 that had not been previously reported under Rule 16a-11.
Crescent Capital BDC, Inc. (CCAP) reported that Chief Financial Officer Lombard Gerhard purchased 2,000 shares of common stock on 2026-08-19 in an open-market transaction at a weighted average price of $10.91 per share. Following this trade and previously unreported dividend reinvestments, his direct holdings total 40,509 shares.
Crescent Capital BDC, Inc. reported second quarter 2026 results for the quarter ended June 30, 2026. Net investment income was $13.1 million, or $0.36 per share, while net income was a loss of $0.09 per share, reflecting net realized and unrealized losses on investments.
Total investment income was $36.3 million, down from $37.9 million in the prior quarter and $43.0 million a year earlier, mainly due to lower dividend income from its Logan JV and reduced accelerated amortization and prepayment fee income. Net asset value was $656.5 million, or $17.82 per share, compared with $19.55 a year earlier.
The investment portfolio had a fair value of $1,570.7 million across 192 portfolio companies, with 98.4% of debt investments at floating rates and a weighted average yield on income-producing securities of 9.6%. The board declared a third quarter 2026 regular cash dividend of $0.34 per share and the second of three $0.03 per share special dividends. Liquidity at June 30, 2026 included $35.7 million in cash and $199.6 million of undrawn credit capacity, with a net debt-to-equity ratio of 1.37x.